Food and Drug Administration
agency of the US Department of Health and Human Services
Entity sentiment
Events
01.07.2024Labour Party wins the general election
01.07.2024Labour Party wins the general election
Express your sentiment!
Related
News
Opinions
Statements
society 2025-07-03 09:34
FDA vaccine official imposes new limits on COVID vaccine approvals - Dr. Vinay Prasad imposed restrictions on COVID vaccine approvals for Novavax and Moderna, despite prior analyses by FDA scientists suggesting broader access.
- The decision to limit vaccine availability to specific high-risk groups reflects ongoing tensions within the FDA regarding vaccine safety and effectiveness.
- These actions raise concerns about the public health implications of restricting COVID vaccine access amid ongoing health threats posed by the virus.
00
society 2025-06-20 00:00
FDA gives risky drugs from banned factories a pass - ProPublica's investigation revealed the FDA allowed over 150 drugs from factories with manufacturing violations into the U.S. market.
- The FDA claimed these drugs were deemed safe after additional testing but faced criticism for not informing the public of the exemptions.
- The practice raised concerns about public health and the integrity of the FDA's regulatory process.
00
society 2025-06-19 04:44
New Zealand approves psilocybin to treat depression - New Zealand has approved psilocybin for therapeutic use by select psychiatrists.
- This decision allows for the treatment of patients with treatment-resistant depression.
- The approval reflects a broader trend in recognizing psychedelics for mental health treatments.
00
society 2025-06-04 15:39
FDA commissioner reviews safety of abortion drug mifepristone amid concerns - Marty Makary, FDA Commissioner, announced a review of mifepristone safety after a concerning study.
- The study indicated that 11% of women experienced severe side effects, substantially higher than current labeling.
- The review may lead to potential changes in regulations regarding medical abortion drugs.
00
society 2025-06-04 10:00
FDA raises tomato recall to highest risk after deadly contamination fears - H&C Farms Label tomatoes were linked to a salmonella contamination risk, prompting a recall.
- The FDA elevated this recall to a Class I designation due to the serious health risks involved.
- Consumers are advised to discard any affected tomatoes to prevent potential illness.
00
society 2025-05-31 17:05
FDA approves Moderna's new lower-dose COVID-19 vaccine with usage limits - The FDA approved Moderna's new COVID-19 vaccine, mNexspike, with specific usage limits for certain age groups.
- The approval was based on a study demonstrating the new vaccine's safety and effectiveness compared to the existing vaccine.
- This new low-dose vaccine aims to protect those at higher risk and represents a strategic shift in COVID-19 vaccination policies.
00
society 2025-05-23 15:10
FDA advisors select strain for this year's COVID vaccine - Expert advisors for the FDA met to select a strain for updated COVID-19 vaccines ahead of the vaccination season.
- The advisors voted unanimously to target the JN.1 lineage, stemming from WHO recommendations, amidst discussions about the possible need for new trials.
- There are significant regulatory uncertainties and ethical concerns regarding the implementation of new vaccine formulations, highlighting the importance of swift decision-making.
00
business 2025-05-22 16:19
Federal officials seize $34 million in illegal e-cigarettes from China - Federal officials seized nearly $34 million worth of illegal e-cigarettes in February from China.
- The FDA has warned 24 companies and issued over 750 warning letters to unauthorized vendors.
- The ongoing crackdown aims to protect youth from unauthorized vaping products.
00
technology 2025-05-22 00:00
FDA announces generative AI deployment by June 2025 - The FDA plans to implement generative AI technology agency-wide by June 2025.
- This technology aims to improve document review and regulatory compliance tracking.
- The successful pilot of AI in scientific reviews has led to an accelerated timeline for its broader adoption.
00
society 2025-05-21 13:16
FDA narrows COVID-19 vaccine access to older adults and high-risk groups - The FDA has introduced new approval standards for COVID-19 vaccines prioritizing older adults and high-risk populations.
- Future vaccinations for healthy individuals will rely on more rigorous clinical evidence, limiting their access to new vaccines.
- This policy change could significantly reduce vaccination availability for younger, healthier demographics, causing ongoing public health concerns.
00
business 2025-05-07 00:00
Hamdi Ulukaya invests $1.7 billion to transform dairy farming - Hamdi Ulukaya announced a $1.2 billion investment for a new dairy facility in New York.
- He has also committed an additional $500 million to expand operations in Idaho.
- These investments aim to improve food accessibility and quality in the dairy industry.
00
society 2025-05-06 19:48
Vinay Prasad takes charge of FDA's biologics and vaccines division amid controversies - Dr. Vinay Prasad is appointed to lead the FDA's Center for Biologics Evaluation and Research.
- He replaces Dr. Peter Marks, who resigned due to concerns over vaccine safety policies.
- Prasad's critical stance on vaccines may influence future FDA vaccine regulations.
00
science 2025-05-06 19:48
Vinay Prasad takes charge of FDA vaccine program amidst controversy - Dr. Vinay Prasad has been named the head of the FDA's Center for Biologics Evaluation and Research.
- His appointment is part of a trend of bringing critics of conventional medical practices into government roles.
- Concerns have been raised that Prasad's leadership may lead to increased scrutiny of vaccines and hinder their approval.
00
technology 2025-05-06 12:42
Avant Technologies and Ainnova set for crucial FDA meeting on Vision AI platform - The FDA has scheduled a pre-submission meeting for Avant Technologies and Ainnova on July 7, 2025.
- The meeting will focus on the planned clinical trial for Ainnova's Vision AI platform technology.
- Successful engagement with the FDA is crucial for the commercial potential of Ainnova's technology in the U.S. market.
00
business 2025-05-05 00:00
California lettuce industry elevates safety standards amid FDA challenges - The California Leafy Greens Marketing Agreement governs rigorous food safety standards to prevent foodborne illnesses.
- Members of LGMA represent about 98% to 99% of California's lettuce production, equating to over 55 billion servings consumed annually.
- Despite high compliance, localized foodborne outbreaks have raised concerns, highlighting the importance of continuous safety improvements.
00
society 2025-05-02 00:00
FDA plans to reinstate fired employees amid staffing crisis - The FDA has announced plans to rehire some of the staff members recently laid off amid significant budget and departmental changes.
- Mass layoffs led to confusion and uncertainty about employee status and operational capabilities.
- The reinstatement reflects ongoing efforts to address disruptions and challenges in maintaining essential government functions.
00
science 2025-04-29 12:00
Biomay secures FDA approval for Cas9 nuclease production - Biomay received FDA approval for manufacturing recombinant Cas9 nuclease at its headquarters in Vienna, Seestadt.
- The approval came after an FDA inspection found no observations, allowing the site to supply the U.S. market.
- This achievement underscores Biomay’s commitment to high-quality manufacturing standards in the biotechnology sector.
00
science 2025-04-13 11:47
Trump administration announces end to cruel animal testing practices - The Trump administration has announced plans to phase out animal testing for drug development at both the FDA and EPA.
- This shift replaces traditional animal testing with AI-based and human organ models, aiming to expedite safer treatments.
- Animal advocacy groups praise these changes, yet some experts caution that humane animal testing still plays a crucial role.
00
society 2025-04-04 18:44
Trump administration dismantles FDA's bird flu response team amid outbreak - The Trump administration cut members of the FDA’s bird flu response team despite rising case numbers.
- These layoffs removed critical personnel responsible for managing and monitoring bird flu outbreaks.
- Experts warn that the combination of staff reductions and bird migration may lead to increased risks for new virus variants.
00
society 2025-04-03 21:30
Cromer Food Services recalls chicken salad sandwiches over undeclared milk allergens 
politics 2025-04-03 01:15
Supreme Court backs FDA's ban on flavored e-cigarettes - The U.S. Supreme Court ruled in a 9-0 unanimous decision favoring the FDA's authority over flavored vaping products.
- This decision affirms the FDA's position that flavored e-cigarettes are particularly appealing to minors and pose health risks.
- The ruling establishes a precedent for future FDA regulatory actions regarding tobacco products and flavored e-cigarettes.
00
society 2025-03-30 00:00
Thousands of pounds of ground coffee recalled for mislabeling as decaffeinated - The FDA recalled thousands of ground coffee packages due to a labeling error.
- The recall affects coffee sold in 15 states, impacting over 4,152 packages.
- Consumers are urged to check their coffee for correct labeling to ensure safety.
00
politics 2025-03-26 15:06
Marty Makary confirmed as FDA commissioner amid scrutiny - The Senate confirmed Marty Makary as FDA commissioner with a vote of 56-44.
- Concerns about his stance on abortion and vaccination regulation arose during confirmation hearings.
- Makary's appointment signals a shift in federal health policies under the Trump administration.
00
society 2025-03-18 17:51
FDA employees face chaos while returning to office under new mandate - Thousands of FDA employees returned to their headquarters as mandated by the federal government.
- Employees encountered severe logistical problems, including long security lines, no office supplies, and overflowing parking.
- The chaotic situation reflects a lack of preparation for the sudden shift back to in-person work amid ongoing safety concerns.
00
society 2025-02-25 03:45
FDA fires and rehired hundreds of staff amid chaos - The Food and Drug Administration recently fired a large number of staff members, particularly from its medical devices center.
- These firings were part of a broader initiative led by the Department of Government Efficiency under Elon Musk.
- The subsequent rehiring of some employees indicates the ongoing need for experienced staff within the agency.
00
society 2025-02-19 00:00
FDA prioritizes ideology over drug safety under Biden administration - The FDA has faced criticism for prioritizing ideology over drug safety.
- Recent studies show significant risks associated with puberty blockers and cross-sex hormones.
- There is a pressing need for the FDA to ensure independent and transparent drug safety monitoring.
00
science 2025-01-30 00:30
FDA expands Ozempic's use to combat chronic kidney disease in diabetes patients - The FDA approved Ozempic for treating chronic kidney disease in Type 2 diabetes patients, allowing it to mitigate the risk of worsening kidney function.
- This decision may change how healthcare providers treat chronic kidney disease, which often coexists with diabetes.
- Ozempic's approval signifies broader health benefits of GLP-1 medications in addressing metabolic-related health issues.
00
society 2025-01-07 15:26
FDA introduces lead limits in baby foods to protect infants - The FDA has established maximum lead levels in baby foods for the first time, aiming to reduce children's exposure.
- Consumer advocates argue the new guidance is insufficient and does not cover all food categories with potential lead contamination.
- Despite this initial step, critics emphasize the need for more stringent regulations to eliminate lead exposure in children's foods.
00
society 2024-12-28 08:20
FDA demands action to ban asbestos from talc cosmetics - The FDA has proposed a new rule mandating standardized testing for asbestos in talc-containing cosmetics.
- This rule aims to protect consumers from potential health risks associated with asbestos exposure.
- Implementation of these standards comes amid numerous lawsuits against major companies like Johnson & Johnson for alleged links between talc and cancer.
00
society 2024-12-23 14:06
FDA admits phenylephrine decongestant doesn't work—what now? - The FDA has proposed revoking the use of phenylephrine in over-the-counter cold and allergy medications.
- Research has indicated that phenylephrine, even at high doses, is ineffective in treating nasal congestion.
- Consumers may need to seek alternatives as drug manufacturers begin to reformulate their products.
00
society 2024-12-20 21:44
FDA approval of Zepbound sparks debate over weight loss solutions - The FDA approved Zepbound, a weight loss drug, to treat obstructive sleep apnea in adults with obesity.
- The approval is based on clinical trials demonstrating significant weight loss and symptom reduction among participants.
- This development may lead to broader insurance coverage and increased awareness about sleep apnea and its health risks.
00
business 2024-12-16 06:05
MannKind pushes for FDA approval in 2025 amid diabetes treatment controversy - MannKind Corporation announced the results of a Phase 3 study of its inhaled insulin product Afrezza in pediatric patients aged 4-17.
- The trial showed non-inferiority of Afrezza to MDI, with no significant differences in lung function between treatment groups.
- MannKind plans to meet with the FDA to discuss a potential sNDA submission in the first half of 2025.
00
2023 All rights reserved
2023 All rights reserved